Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lexaria Bioscience (LEXX) Shares Outstanding (Diluted Average) (2023 - 2025)

Lexaria Bioscience's Shares Outstanding (Diluted Average) history spans 3 years, with the latest figure at $21.4 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 28.24% year-over-year to $21.4 million; the TTM value through Nov 2025 reached $21.4 million, up 28.24%, while the annual FY2025 figure was $18.0 million, 45.34% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $21.4 million at Lexaria Bioscience, up from $18.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $21.4 million in Q4 2025 and bottomed at $6.6 million in Q3 2023.
  • The 3-year median for Shares Outstanding (Diluted Average) is $15.3 million (2024), against an average of $14.3 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) skyrocketed 87.24% in 2024 before it grew 26.11% in 2025.
  • A 3-year view of Shares Outstanding (Diluted Average) shows it stood at $9.1 million in 2023, then surged by 84.15% to $16.7 million in 2024, then grew by 28.24% to $21.4 million in 2025.
  • Per Business Quant, the three most recent readings for LEXX's Shares Outstanding (Diluted Average) are $21.4 million (Q4 2025), $18.0 million (Q3 2025), and $17.5 million (Q2 2025).